How are the economics of synthetic biology likely to develop in the coming years?
References
Gibson, D.G. et al. Science 319, 1215–1220 (2008).
Shao, Z. & Zhao, H. Nucleic Acids Res. 37, e16 (2009).
Borokov, A. SynBuild, an accurate high-throughput gene assembly platform that uses microarray synthesized oligos. Poster at Synthetic Biology 4.0, Hong Kong, China, October 10–12, 2008.
Gibson, D.G. Nucleic Acids Res. published online, 10.1093/nar/gkp687 (10 September 2009).
Keasling, J.D. Synthetic biology in pursuit of low-cost, effective, anti-malarial drugs. Presentation at the Institute for Systems Biology Seventh Annual International Symposium, Seattle, April 21, 2008.
Carlson, R. Nat. Biotechnol. 27, 984 (2009).
Carlson, R. Syst. Synth. Biol. 1, 109–117 (2007).
Carlson, R. Biology is Technology (Harvard University Press, Cambridge, in the press).
Newcomb, J., Carlson, R. & Aldrich, S. Genome Synthesis and Design Futures: Implications for the US Economy (Bio Economic Research Associates, Cambridge, Massachusetts, 2007).
Garfinkel, M.S., Endy, D., Epstein, G.L. & Friedman, R.M. Synthetic Genomics: Options for Governance (J. Craig Venter Institute, The Center for Strategic and International Studies, Massachusetts Institute of Technology, October 2007). http://www.jcvi.org/cms/fileadmin/site/research/projects/synthetic-genomics-report/synthetic-genomics-report.pdf
Carlson, R. Biosecur. Bioterror. 1, 203–214 (2003).
Khorana, H.G. Science 203, 614–625 (1979).
Mandecki, W., Hayden, M.A., Shallcross, M.A. & Stotland, E. Gene 94, 103–107 (1990).
Stemmer, W.P.C., Crameria, A., Hab, K.D., Brennan, T.M. & Heynekerb, H.L. Gene 164, 49–53 (1995).
Cello, J., Paul, A.V. & Wimmer, E. Science 297, 1016–1018 (2002).
Tian, J. et al. Nature 432, 1050–1054 (2004).
Kodumal, S.J. et al. Proc. Natl. Acad. Sci. USA 101, 15573–15578 (2004).
Acknowledgements
Portions of this text are drawn from Biology is Technology, scheduled for publication in 2010. I would like to thank J. Mulligan, J. Minshull, J. Koschwanez, L. Stewart, D. Endy and R. Wehbring for illuminating and entertaining discussions.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Novici, one of the companies mentioned in this article, is a client of R.C.’s company Biodesic.
Rights and permissions
About this article
Cite this article
Carlson, R. The changing economics of DNA synthesis. Nat Biotechnol 27, 1091–1094 (2009). https://doi.org/10.1038/nbt1209-1091
Issue Date:
DOI: https://doi.org/10.1038/nbt1209-1091
- Springer Nature America, Inc.
This article is cited by
-
Programmable self-regulated molecular buffers for precise sustained drug delivery
Nature Communications (2022)
-
Creating CRISPR-responsive smart materials for diagnostics and programmable cargo release
Nature Protocols (2020)
-
The accelerating pace of biotech democratization
Nature Biotechnology (2019)
-
Encoding information into polymers
Nature Reviews Chemistry (2018)
-
Gene synthesis allows biologists to source genes from farther away in the tree of life
Nature Communications (2018)